Artificial pancreas: From in-silico to in-vivo

IFAC-PapersOnLine

Volumn 28, Issue 8, 2015, Pages 1300-1308

  Messori, M ^a   Cobelli, C ^b   Magni, L ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Artificial pancreas; Biomedical control; Biomedical systems; Linear systems; Predictive control

Indexed keywords

ARTIFICIAL ORGANS; CLOSED LOOP SYSTEMS; GLUCOSE SENSORS; LINEAR SYSTEMS; MODEL PREDICTIVE CONTROL;

ARTIFICIAL PANCREAS; BIOMEDICAL CONTROL; BIOMEDICAL SYSTEMS; CLINICAL ENVIRONMENTS; FOOD AND DRUG ADMINISTRATION; IN-VIVO EXPERIMENTS; PERFORMANCE INDICES; PREDICTIVE CONTROL;

CONTROLLED DRUG DELIVERY;

EID: 84992496435     PISSN: None     EISSN: 24058963     Source Type: Conference Proceeding    
DOI: 10.1016/j.ifacol.2015.09.148     Document Type: Conference Paper

References (51)

1. E. Atlas, R. Nimri, S. Miller, E.A. Grunberg, and M. Phillip. MD-Logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care, 33(5):1072-1076, 2010.
2. B.W. Bequette. Challenges and recent progress in the development of a closed-loop artificial pancreas. Annu Rev Control, 36(2):255-266, 2012.
3. M. Breton, A. Farret, D. Bruttomesso, S. Anderson, L. Magni, S. Patek, C. Dalla Man, J. Place, S. Demartini, S. Del Favero, C. Toffanin, C. Hughes, E. Dassau, H. Zisser, F.J. Doyle III, G. De Nicolao, A. Avogaro, C. Cobelli, E. Renard, and B. Kovatchev, on behalf of the International Artificial Pancreas (IAP) study group. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes, 61(9):2230-2237, 2012.
4. D. Capozzi and G. Lanzola. A generic telemedicine infrastructure for monitoring an artificial pancreas trial. Comput Meth Prog Bio, 110(3):343-353, 2013.
5. H.P. Chase, F.J. Doyle III, H. Zisser, E. Renard, R. Nimri, C. Cobelli, B.A. Buckingham, D.M. Maahs, S. Anderson, L. Magni, J. Lum, P. Calhoun, C. Kollman, and R.W. Beck, for the Control to Range Study Group. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes. Diabetes Technol Ther, 16(10): 623-632, 2014.
6. C. Cobelli, C. Dalla Man, G. Sparacino, L. Magni, G. De Nicolao, and B.P. Kovatchev. Diabetes: models, signals, and control". IEEE Rev Biomed Eng, 2:54-96, 2009.
7. C. Cobelli, E. Renard, and B. Kovatchev. Artificial pancreas: past, present, future. Diabetes, 60(11):2672-2682, 2011.
8. C. Dalla Man, F. Micheletto, D. Lv, M. Breton, B.P. Kovatchev, and C. Cobelli. The UVA/Padova type 1 diabetes simulator: new features. J Diabetes Sci Technol, 8(1):26-34, 2014.
9. E. Dassau, H. Zisser, C. C. Palerm, B. A. Buckingham, L. Jovanovic, F. J. Doyle III. Modular artificial -Cell system: a prototype for clinical research. J Diabetes Sci Technol, 2(5):863-872, 2008.
10. S. Del Favero, D. Bruttomesso, F. Di Palma, G. Lanzola, R. Visentin, A. Filippi, R. Scotton, C. Toffanin, M. Messori, S. Scarpellini, P. Keith-Hynes, B.P. Kovatchev, J.H. DeVries, E. Renard, L. Magni, A. Avogaro, and C. Cobelli, on behalf of the AP@home consortium. First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care, 37(5):1212-1215, 2014.
11. S. Del Favero, J. Place, J. Kropff, M. Messori, P. Keith-Hynes, R. Visentin, M. Munaro, D. Bruttomesso, S. Galasso, F. Boscari, C. Toffanin, F. Di Palma, G. Lanzola, S. Scarpellini, A. Ferret, B. Kovatchev, L. Magni, A. Avogaro, J. H. DeVries, C. Cobelli, E. Renard, on behalf of the AP@home Consortium. Multicentre outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using multi-modular model predictive control algorithm in adults with type 1 diabetes. Diabetes Obes Metab, DOI: 10.1111/dom.12440, 2015.
12. F. J. Doyle, B. Srinivasan, and D. Bonvin. Run-To-Run control strategy for diabetes management. Engineering in Medicine and Biology Society, 2001. Proceedings of the 23rd Annual International Conference of the IEEE, 4:3159-3162, 2001.
13. P. Dua, F.J. Doyle III, and E.N. Pistikopoulos. Model-based blood glucose control for type 1 diabetes via parametric programming. IEEE Trans Biomed Eng 53(8):1478-1491, 2006.
14. F.H. El-Khatib, S.J. Russell, D.M. Nathan, R.G. Sutherlin, and E.R. Damiano. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med, 2(27): 27ra27, 2010.
15. B. Grosman, E. Dassau, H.C. Zisser, L. Jovanovic, and F.J. Doyle III. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol, 4(4):961-975, 2010.
16. R. Hovorka, V. Canonico, L.J. Chassin, U. Haueter, M. Massi-Benedetti, M.O. Federici, T.R. Pieber, H.C. Schaller, L. Schaupp, T. Vering, and M.E. Wilinska. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas, 25:905-920, 2004.
17. R. Hovorka. Management of diabetes using adaptive control. Int J Adapt Control, 19(5):309-325, 2005.
18. R. Hovorka. Continuous glucose monitoring and closed-loop systems. Diabetic Med, 23(1):1-12, 2006.
19. R. Hovorka, J.M. Allen, D. Elleri, L.J. Chassin, J. Harris, D. Xing, C. Kollman, T. Hovorka, A.M.F. Larsen, M. Nodale, A. De Palma, M.E. Wilinska, C.L. Acerini, and D.B. Dunger. Manual closed-loop insulin delivery in children and adolescent with type 1 diabetes: a phase 2 randomised crossover trial. Lancet, 375:743-751, 2010.
20. P. Keith-Hynes, B. Mize, A. Robert, and J. Place. The diabetes assistant: a smartphone-based system for realtime control of blood glucose. Electronics, 3:609-623, 2014.
21. B.P. Kovatchev, S. Patek, E. Dassau, F.J. Doyle III, L. Magni, G. De Nicolao, and C. Cobelli, for the Juvenile Diabetes Research Foundation Artificial Pancreas Consortium. Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol, 3(5): 1058-1065, 2009.
22. B.P. Kovatchev, C. Cobelli, E. Renard, S. Anderson, M. Breton, S. Patek, W. Clarke, D. Bruttomesso, A. Maran, S. Costa, A. Avogaro, C. Dalla Man, A. Facchinetti, L. Magni, G. De Nicolao, J. Place, and A. Farret. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results". J Diabetes Sci Technol, 4(6):1374-1381, 2010.
23. Kovatchev BP, Keith-Hynes PT, Breton MD, and Patek SD. Unified platform for monitoring and control of blood glucose levels in diabetic patients. U.S. Patent Application Number PCT/US2012/043910, June 23, 2012
24. B.P. Kovatchev, E. Renard, C. Cobelli, H.C. Zisser, P. Keith-Hynes, S. M. Anderson, S. A. Brown, D. R. Chernavvsky, M.D. Breton, L.B. Mize, A. Farret, J. Place, D. Bruttomesso, S. Del Favero, F. Boscari, S. Galasso, A. Avogaro, L. Magni, F. Di Palma, C. Toffanin, M. Messori, E. Dassau, and F.J. Doyle III. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care, 37(7):1789-1796, 2014.
25. G. Lanzola, D. Capozzi, N. Serina, L. Magni, and R. Bellazzi. Bringing the artificial pancreas home: telemedicine aspects. J Diabetes Sci Technol, 5(6):1381-1386, 2011.
26. G. Lanzola, S. Scarpellini, F. Di Palma, C. Toffanin, S. Del Favero, L. Magni, and R. Bellazzi, on behalf of the AP@home consortium. Monitoring artificial pancreas trials through agent-based technologies: a case report. J Diabetes Sci Technol, 8(2):216-224, 2014.
27. Y. M. Luijf, J. H. DeVries, K. Zwinderman, L. Lee-larathna, M. Nodale, K. Caldwell, K. Kumareswaran, D. Elleri, J. M. Allen, M. E. Wilinska, M. L. Evans, R. Hovorka, W. Doll, M. Ellmerer, J. K. Mader, E. Renard, J. Place, A. Farret, C. Cobelli, S. Del Favero, C. Dalla Man, A. Avogaro, D. Bruttomesso, A. Filippi, R. Scotton, L. Magni, G. Lanzola, F. Di Palma, P. Soru, C. Toffanin, G. De Nicolao, S. Arnolds, C. Benesch, and L. Heinemann. Day and night closed-loop control in adults with type 1 diabetes mellitus: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care, 36(12):3882-3887, 2013.
28. L. Magni, D.M. Raimondo, L. Bossi, C. Dalla Man, G. De Nicolao, B. Kovatchev, and C. Cobelli. Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Technol, 1(6):804-812, 2007.
29. L. Magni, D.M. Raimondo, C. Dalla Man, G. De Nicolao, B. P. Kovatchev, and C. Cobelli. Model predictive control of glucose concentration in type I diabetic patients: an in silico trial. Biomed Signal Proces, 4(4):338-346, 2009.
30. L. Magni, M. Forgione, C. Toffanin, C. Dalla Man, G. De Nicolao, B. Kovatchev, and C. Cobelli. Run-to-Run tuning of model predictive control for type I diabetic subjects: an in silico trial. J Diabetes Sci Technol, 3(5): 1091-1098, 2009.
31. V. Maheshwari, G.P. Rangaiah, and L. Samavedham. A novel multi-objective optimization based experimental design and its application for physiological model of type 1 diabetes. Advanced Control of Chemical Processes, 8(1):638-643, 2012.
32. G. Marchetti, M. Barolo, L. Jovanovicy, H. Zissery, and D. Seborg. An improved PID switching control strategy for type 1 diabetes. IEEE Trans Biomed Eng, 55(3): 857-865, 2008.
33. M. Messori, E. Fornasiero, C. Toffanin, C. Cobelli, and L. Magni. A constrained model predictive controller for an artificial pancreas. 19th IFAC World Congress, Cape Town, South Africa, 10144-10149, 2014.
34. M. Messori, M. Ellis, C. Cobelli, P.D. Christofides, and L. Magni. Improved postprandial glucose control with a customized model predictive controller. P Amer Contr Conf, Chicago, IL, 2015.
35. C. Owens, H. Zisser, L. Jovanovic, B. Srinivasan, D. Bonvin, and F.J. Doyle III. Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus. IEEE Trans Biomed Eng, 53(6):996-1005, 2006.
36. C.C. Palerm, H. Zisser, W. Bevier, L. Jovanovic, and F.J. Doyle III. Prandial insulin dosing using run-to-run control application of clinical data and medical expertise to define a suitable performance metric. Diabetes Care, 30(5):1131-1136, 2007.
37. C.C. Palerm, H. Zisser, L. Jovanovic, and F.J. Doyle III. A run-to-run framework for prandial insulin dosing: handling real-life uncertainty. Int J Robust Nonlin, 17(13):1194-1213, 2007.
38. C.C. Palerm, H. Zisser, L. Jovanovic, and F.J. Doyle III. A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes. J Process Control, 18(3):258-265, 2008.
39. R.S. Parker, F.J. Doyle III, and N.A. Peppas. A model-based algorithm for blood glucose control in type 1 diabetic patients. IEEE Trans Biomed Eng, 46(2):148-157, 1999.
40. R.S. Parker, E.P. Gatzke, and F.J. Doyle III. Advanced model predictive control (MPC) for type I diabetic patient blood glucose control. P Amer Contr Conf, Chicago, IL, 2000.
41. S.D. Patek, L. Magni, E. Dassau, C.S. Hughes, C. Toffanin, G. De Nicolao, M. Breton, C. Dalla Man, E. Renard, H. Zisser, F.J. Doyle III, C. Cobelli, and B.P. Kovatchev. Modular closed-loop control of diabetes. IEEE Trans Biomed Eng, 59(11):2986-2999, 2012.
42. E.F. Pfeiffer, C. Thum, and A.H. Clemens. The artificial beta cell - a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res, 6:339-342, 1974.
43. S.J. Russell, F.H. El-Khatib, M.Sinha, K.L. Magyar, K. McKeon, L.G. Goergen, C.Balliro, M.A. Hillard, D.M. Nathan, and E.R. Damiano. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med, 371:313-325, 2014.
44. P. Soru, G. De Nicolao, C. Toffanin, C. Dalla Man, C. Cobelli, and L. Magni, on behalf of the AP@home consortium. MPC based artificial pancreas: strategies for individualization and meal compensation. Annu Rev Control, 36(1):118-128, 2012.
45. G. M. Steil, K. Rebrin, C. Darwin, F. Hariri, and M.F. Saad. Feasibility of automatic insulin delivery for the treatment of type 1 diabetes. Diabetes, 55(12):3344-3350, 2006.
46. H. Thabit, A. Lubina-Solomon, M.Stadler, L. Leelarathna, E. Walkinshaw, A. Pernet, J.M. Allen, A. Iqbal, P. Choudhary, K. Kumareswaran, M. Nodale, C. Nisbet, M.E. Wilinska, K.D. Barnard, D.B. Dunger, S.R. Heller, S.A. Amiel, M.L. Evans, and R. Hovorka. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multi-centre, randomised crossover study. Lancet Diabetes Endocrinol, 2(9):701-709, 2014.
47. C. Toffanin, M. Messori, F. Di Palma, G. De Nicolao, C. Cobelli, and L. Magni. Artificial pancreas: model predictive control design from clinical experience. J Diabetes Sci Technol, 7(6):1470-1483, 2013.
48. C. Toffanin, A. Sandri, M. Messori, C. Cobelli, and L. Magni. Automatic adaptation of basal therapy for type 1 diabetic patients: a run-to-run approach. 19th IFAC World Congress, Cape Town, South Africa, 2070-2075, 2014.
49. S.A. Weinzimer, G.M. Steil, K.L. Swan, J. Dziura, N. Kurtz, and W.V. Tamborlane. Fully-automated closed-loop insulin delivery versus semi-automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care, 31(5):934-939, 2008.
50. H. Zisser, L. Jovanovic, F.J. Doyle III, P. Ospina, and C. Owens. Run-to-Run control of meal-related insulin dosing. Diabetes Technol Ther, 7(1):48-57, 2005.
51. H. Zisser, E. Renard, B. Kovatchev, C. Cobelli, A. Avog-aro, R. Nimri, L. Magni, B. Buckingham, H.P. Chase, F. J. Doyle III, J. Lum, P. Calhoun, C. Kollman, E. Dassau, A. Farret, J. Place, M. Breton, S. Anderson, C. Dalla Man, S. Del Favero, D. Bruttomesso, A. Filippi, R. Scotton, M. Phillip, E. Atlas, I. Muller, S. Miller, C. Toffanin, D. M. Raimondo, G. De Nicolao, and R.W. Beck, for the control to range study group. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. Diabetes Technol Ther, 16(10):613-622, 2014.